AI-based mammography is here — with a trust issue

Radiologists' skepticism is in part driven by the limited evidence on how the new technology improves cancer outcomes

May 30, 2025 Check out STAT+

Sponsored By

Hey. Do you know a stellar young scientist? We invite you to nominate them for STAT Wunderkinds, our annual contest to celebrate early-career researchers who are not yet independent scientists or program leaders. Thanks for reading!

Adobe STAT+ | AI-based mammography is here, and it has a trust problem Despite FDA clearance, AI breast cancer detection tools face skepticism from some radiologists who are slow to trust new mammogram screening tools. By Katie Palmer Moderna's vaccine hit, the MAHA report, and an ASCO preview On this week's podcast, STAT's Helen Branswell talks about BARDA cancelling its contract with Moderna and RFK Jr.'s unprecedented move on Covid shots. By Allison DeAngelis, Adam Feuerstein, and Elaine Chen STAT+ | Summit shows mixed results from key study of lung cancer drug Ivonescimab, which had been previously tested in China, has been closely tracked for its blockbuster potential. By Adam Feuerstein Courtesy Julie O'Shaughnessy STAT+ | As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser